Skip to main content
. 2023 Aug 9;14:1162786. doi: 10.3389/fendo.2023.1162786

Table 4.

Putative miR-10a-5p target genes downregulated in OCCC with concurrent endometriosis within the receptor signaling pathway.

Gene Name description log2FoldChange P adj
ACVR2A activin A receptor type 2A -1.52 5.14E-05
ARRDC3 arrestin domain containing 3 -2.11 1.38E-05
BAMBI BMP and activin membrane bound inhibitor -2.57 1.03E-10
BDNF brain derived neurotrophic factor -2.42 4.93E-04
DLG4 discs large MAGUK scaffold protein 4 -1.55 7.17E-06
EPHA4 EPH receptor A4 -3.29 2.75E-13
FEM1B fem-1 homolog B -1.56 3.87E-09
FHL2 four and a half LIM domains 2 -2.70 1.60E-08
FLRT2 fibronectin leucine rich transmembrane protein 2 -3.15 5.94E-13
GNAL G protein subunit alpha L -3.60 3.56E-06
HLA-E major histocompatibility complex, class I, E -1.32 4.39E-03
IL12A interleukin 12A -1.82 4.61E-02
IRS1 insulin receptor substrate 1 -1.54 1.10E-02
MMP14 matrix metallopeptidase 14 -2.98 9.40E-06
NEDD4 NEDD4 E3 ubiquitin protein ligase -1.48 6.79E-05
PANX1 pannexin 1 -2.03 2.86E-06
PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma -2.49 2.24E-05
PLSCR1 phospholipid scramblase 1 -1.37 4.91E-02
SERPINE1 serpin family E member 1 -4.78 1.10E-06
TGFB3 transforming growth factor beta 3 -3.11 2.05E-12
TNFRSF8 TNF receptor superfamily member 8 -2.93 4.28E-03
VDR vitamin D receptor -2.12 4.67E-02